Oncimmune (LON:ONC) Stock Price Down 2.5% – Should You Sell?

Oncimmune Holdings plc (LON:ONC) traded down 2.5% during trading on Thursday . The company traded as low as GBX 8 ($0.10) and last traded at GBX 9.95 ($0.12). 378,794 shares changed hands during mid-day trading, an increase of 34% from the average session volume of 281,822 shares. The stock had previously closed at GBX 10.20 ($0.13).

Oncimmune Price Performance

The company has a current ratio of 1.13, a quick ratio of 0.63 and a debt-to-equity ratio of 806.85. The firm has a market capitalization of £7.00 million, a PE ratio of -314.57 and a beta of 1.19. The business has a 50-day moving average of GBX 13.81 and a 200 day moving average of GBX 14.84.

Oncimmune Company Profile

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.